Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOMATCAN is a private Canadian medical device and biomaterials company focused on synthetic orthobiologics for bone regeneration. The company develops, manufactures, packages, sterilizes, and markets synthetic bone substitute products for orthopedic, dental, and skull-maxillofacial applications. Its technology is centered on high-purity calcium phosphate bioceramics, including biphasic calcium phosphate formulations designed to support osteoconduction, bioactivity, and controlled resorption. BIOMATCAN emphasizes fully synthetic products with no human or animal tissue, positioning them as safer alternatives to autograft, allograft, and xenograft materials. The company also operates a certified manufacturing facility in New Brunswick, Canada and promotes collaborations and manufacturing services for biomaterial development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOMATCAN.